SEC Form 4 · accession 0001161697-15-000201
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David D Muth
Officer — EVP, Chief Commercial Officer
Period of report
Apr 28, 2015
Accepted (ET)
Apr 30, 2015 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | Apr 28, 2015 | P | 1,700 | $3.549 | A | 42,700 | D | |
| Common Stock, par value $0.001 per share | Apr 28, 2015 | P | 300 | $3.55 | A | 43,000 | D |
Table II — derivative securities
No Table II lines on this filing.